KOD Live signaler | Maksimer profitt med Getagraph.com

KJøP 111095 min ago

@ $4.87

Utstedt: 14 feb 2024 @ 19:51

Avkastning: -27.52%

Forrige signal: feb 14 - 15:33

Forrige signal: Selg

Avkastning: -1.22 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Stats
Dagens volum	506 491
Gjennomsnittsvolum	834 395
Markedsverdi	185.41M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $-1.090 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.0140 (0.40%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-30	Baker Bros. Advisors Lp	Buy	40 000	Non-Qualified Stock Options (right to buy)
2023-06-30	Yang Taiyin	Buy	40 000	Stock Option (Right to Buy)
2023-06-30	Profusek Robert	Buy	40 000	Stock Option (Right to Buy)
2023-06-30	Levy Richard S	Buy	40 000	Stock Option (Right to Buy)
2023-06-30	Dahiyat Bassil I	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
96.05
Last 99 transactions
Buy: 3 824 931 \| Sell: 1 385 823

Volum Korrelasjon

Lang: 0.50 (neutral)

Kort: -0.71 (moderate negative)

Signal:(36.51) Neutral

Kodiak Sciences Inc Korrelasjon

10 Mest positive korrelasjoner
SONN	0.914
VERU	0.908
VNET	0.908
INFI	0.906
DZSI	0.903
LIVN	0.902
TCX	0.902
RYTM	0.901
PCVX	0.899
FNWB	0.897

10 Mest negative korrelasjoner
TYHT	-0.933
AAON	-0.913
GSHD	-0.912
PLPC	-0.905
ZGNX	-0.903
CNCE	-0.901
LNTH	-0.9
CPTA	-0.897
LMNR	-0.895
ADMS	-0.893

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Kodiak Sciences Inc Korrelasjon - Valuta/Råvare

-0.76
( moderate negative )

-0.74
( moderate negative )

-0.80
( moderate negative )

0.24
( neutral )

-0.58
( weak negative )

Kodiak Sciences Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-25.95M (0.00 %)
EPS:	$-4.97

FY	2023
Omsetning:	$0
Bruttogevinst:	$-25.95M (0.00 %)
EPS:	$-4.97

FY	2022
Omsetning:	$0
Bruttogevinst:	$-11.00M (0.00 %)
EPS:	$6 502.21

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-5.16

Financial Reports:

No articles found.

Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.